(R)-23a

N/A

Report date: 2024/09/20 14:48:07
NME

Base Information

Drug Name(R)-23a
Drug Alias Name(R)-23a
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitorsHistone deacetylase inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1Histone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong UniversityChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A